Iovance Biotherapeutics, Inc. (IOVA)
Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)
As of Oct 21, 2:16 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow IOVA in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on IOVA and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
IOVA at a glance
Key statistics
$6.73B
Market capitalization
- Previous close
- $14.86
- Open
- $14.95
- Day range
- $14.70 – $15.33
- Volume
- 7.72M
- Average volume (30 sessions)
- 16.73M
- Shares outstanding
- 452.97M
- Earnings per share
- $(0.64)
- Price / book
- 9.2
- Price / sales
- 20.7
- Beta (1 year, vs SPY)
- 1.24
Where the price sits in its year
52-week range
96% of the range
- Below the 52-week high
- -3.6%
- Above the 52-week low
- +739.5%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $13.47+10.3%
- 50-day average
- $10.45+42.2%
- 200-day average
- $5.42+174.4%
Between the conventional 30 and 70 bands.
+2.5%
1 week
+45.8%
1 month
+187.4%
3 months
+444.3%
Year to date
+581.7%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with IOVA
IOVA on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on IOVA.
See the plans →
Every planScreen names like IOVA
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on IOVA
Put IOVA on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on IOVA
See whether there is an open premium alert on IOVA, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
IOVA headlines
- Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire Inc. · Oct 1, 2026
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire Inc. · Sep 18, 2026
- Iovance Biotherapeutics to Present at Upcoming Conferences
GlobeNewswire Inc. · Sep 4, 2026
SEC Form 4, most recent first
Insider filings
Berkowitz Noah
+135.0K
Chief Medical Officer · Grant or award
· Sep 30, 2026
Berkowitz Noah
+135.0K
Chief Medical Officer · Grant or award
· Sep 30, 2026
Berkowitz Noah
+180.0K
Chief Medical Officer · Grant or award
· Sep 30, 2026
BILINSKY IGOR
+7.8K
Chief Operating Officer · Option exercise
· Sep 8, 2026
Vogt Frederick G
+15.6K
Interim CEO & General Counsel, Director · Option exercise
· Sep 8, 2026
Puri Raj K.
−9.8K
Chief Regulatory Officer · Option exercise
· Sep 8, 2026
BILINSKY IGOR
−7.8K
Chief Operating Officer · Option exercise
· Sep 8, 2026
Puri Raj K.
+9.8K
Chief Regulatory Officer · Option exercise
· Sep 8, 2026
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Biological Products, (no Diagnostic Substances)
- Headquarters
- San Carlos, CA
- Employees
- 975
- Listed since
- May 26, 2010
- Website
- iovance.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.